Want to see ES:ROVI full AI Analyst Report?
Laboratorios Farmaceuticos Rovi (ROVI) Income Statement
Laboratorios Farmaceuticos Rovi Income Statement
Last quarter (Q2 2026), Laboratorios Farmaceuticos Rovi's total revenue was $191.67M, an increase of 20.02% from the same quarter last year. In Q2, Laboratorios Farmaceuticos Rovi's net income was $75.00M. See Laboratorios Farmaceuticos Rovi’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 743.48M | $ 763.75M | $ 829.51M | $ 817.70M | $ 648.68M | |
| $ 451.65M | $ 478.35M | $ 483.34M | $ 519.61M | $ 384.82M | |
| $ 278.51M | $ 298.80M | $ 263.09M | $ 263.76M | $ 203.34M | |
| Depreciation and Amortization | $ 30.37M | $ 28.02M | $ 24.33M | $ 22.87M | $ 21.36M |
| $ 203.52M | $ 207.69M | $ 245.81M | $ 281.49M | $ 204.72M | |
| $ 173.14M | $ 179.54M | $ 220.25M | $ 255.85M | $ 181.57M | |
| $ 10.12M | $ -1.85M | $ 154.00K | $ 1.92M | $ 1.24M | |
| $ 183.26M | $ 177.69M | $ 220.41M | $ 257.97M | $ 182.63M | |
| $ 140.44M | $ 136.88M | $ 170.34M | $ 199.67M | $ 153.08M | |
| Per Share Metrics | |||||
| Basic EPS | $ 2.75 | $ 2.67 | $ 3.29 | $ 3.73 | $ 2.76 |
| Diluted EPS | $ 2.75 | $ 2.67 | $ 3.29 | $ 3.73 | $ 2.76 |
| Weighted Average Shares Outstanding | 51.15M | 51.27M | 51.82M | 53.47M | 55.40M |
| Weighted Average Shares Outstanding (Diluted) | 51.15M | 51.27M | 51.82M | 53.47M | 55.40M |
Currency in EUR
